Who owns Clearside Biomedical?
- Ticker: CLSD
- CUSIP Number: 185063104
Tip: Access positions for across all investors
Analyze quarterly positions in Clearside Biomedical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Clearside Biomedical stock
Who bought or sold Clearside Biomedical this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.8M | $2.7M | -1% | Dec 2024 |
|
| Carmignac Gestion | 1.9M | $1.8M | 0% | Dec 2024 |
|
| BlackRock | 878k | $834k | 9% | Dec 2024 |
|
| Geode Capital Management | 764k | $726k | 4% | Dec 2024 |
|
| Renaissance Technologies | 722k | $686k | -3% | Dec 2024 |
|
| First Manhattan | 406k | $385k | -39% | Dec 2024 |
|
| State Street Corporation | 265k | $252k | 29% | Dec 2024 |
|
| Bridgeway Capital Management | 255k | $242k | 0% | Dec 2024 |
|
| GCM Grosvenor Holdings | 199k | $252k | 100% | Sep 2024 |
|
| Northern Trust | 166k | $157k | 24% | Dec 2024 |
|
| UBS Group | 145k | $138k | 100% | Dec 2024 |
|
| Morgan Stanley | 132k | $125k | 1% | Dec 2024 |
|
| Assenagon Asset Management | 132k | $125k | -49% | Dec 2024 |
|
| Pnc Financial Services | 108k | $103k | 0% | Dec 2024 |
|
| Captrust Financial Advisors | 101k | $96k | 9% | Dec 2024 |
|
| Brown Wealth Management | 100k | $127k | 0% | Sep 2024 |
|
| Northeast Financial Consultants | 93k | $88k | 0% | Dec 2024 |
|
| Susquehanna International | 71k | $68k | 9% | Dec 2024 |
|
| Newman Dignan & Sheerar | 30k | $29k | 7% | Dec 2024 |
|
| Synovus Financial Corp. | 30k | $29k | -43% | Dec 2024 |
|
| Citadel Advisors | 24k | $23k | -82% | Dec 2024 |
|
| Stifel Financial | 24k | $23k | 4% | Dec 2024 |
|
| Warren Averett Asset Management | 22k | $21k | 0% | Dec 2024 |
|
| Westmount Partners | 22k | $20k | 100% | Dec 2024 |
|
| Two Sigma Securities | 21k | $20k | 100% | Dec 2024 |
|
| Charles Schwab Investment Management | 20k | $19k | 0% | Dec 2024 |
|
| Prudential Financial | 19k | $18k | -45% | Dec 2024 |
|
| Mariner Wealth Advisors | 19k | $18k | 0% | Dec 2024 |
|
| Oppenheimer & Co | 14k | $14k | 100% | Dec 2024 |
|
| Stratos Wealth Advisors | 14k | $13k | 0% | Dec 2024 |
|
| Virtu Financial | 14k | $13k | 100% | Dec 2024 |
|
| Cambridge Investment Research Advisors | 11k | $10k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 10k | $9.8k | 0% | Dec 2024 |
|
| Rockwood Wealth Management | 10k | $9.9k | 0% | Dec 2024 |
|
| Commonwealth Equity Services | 10k | $10k | 0% | Dec 2024 |
|
| Malaga Cove Capital | 10k | $9.5k | 100% | Dec 2024 |
|
| Bank of America Corporation | 6.4k | $6.1k | 5% | Dec 2024 |
|
| Tower Research Capital | 6.0k | $5.7k | 98% | Dec 2024 |
|
| Advisor Group Holdings | 1.2k | $1.5k | 0% | Dec 2024 |
|
| Atlantic Trust | 1.1k | $1.1k | 0% | Dec 2024 |
|
| SBI Securities | 380.00 | $361.000000 | 100% | Dec 2024 |
|
| Russell Investments | 145.00 | $137.996500 | 0% | Dec 2024 |
|
| Creative Financial Designs | 100.00 | $95.000000 | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.00 | $2.000000 | 0% | Dec 2024 |
|
Who sold out of Clearside Biomedical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rosalind Advisors | Sep 2024 | 127k | $162k |
| Millennium Management | Sep 2024 | 91k | $116k |
| Johnson & Johnson | Sep 2024 | 83k | $105k |
| Banque Cantonale Vaudoise | Jun 2024 | 40k | $52k |
| Wolverine Trading | Sep 2024 | 17k | $20k |
| Cubist Systematic Strategies | Sep 2024 | 16k | $20k |
| XTX Topco | Sep 2024 | 16k | $20k |
| Squarepoint Ops | Sep 2024 | 15k | $18k |
| Group One Trading | Sep 2024 | 14k | $17k |
| International Assets Investment Management | Sep 2024 | 13k | $10M |
| Simplex Trading | Sep 2024 | 4.4k | $5.0k |
| Golden State Equity Partners | Sep 2024 | 3.4k | $4.3k |
| Jones Financial Companies, L.L | Sep 2024 | 1.0k | $1.2k |